Confluent (NASDAQ:CFLT) Price Target Raised to $27.00

Confluent (NASDAQ:CFLTFree Report) had its price objective raised by Morgan Stanley from $25.00 to $27.00 in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. They currently have an equal weight rating on the stock.

Other analysts also recently issued reports about the company. Wolfe Research reaffirmed an “outperform” rating and set a $32.00 price objective on shares of Confluent in a research note on Tuesday. Piper Sandler boosted their target price on Confluent from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Tuesday. Wells Fargo & Company started coverage on Confluent in a report on Tuesday, September 30th. They set an “overweight” rating and a $24.00 price target for the company. Cowen lowered shares of Confluent from a “buy” rating to a “hold” rating in a research report on Thursday, July 31st. Finally, Mizuho upped their price objective on shares of Confluent from $24.00 to $26.00 and gave the stock an “outperform” rating in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.97.

Read Our Latest Stock Report on CFLT

Confluent Stock Down 0.5%

Shares of NASDAQ:CFLT opened at $23.52 on Tuesday. Confluent has a 1-year low of $15.64 and a 1-year high of $37.90. The company has a debt-to-equity ratio of 0.98, a current ratio of 4.01 and a quick ratio of 3.98. The stock has a market cap of $8.11 billion, a P/E ratio of -26.13 and a beta of 0.96. The firm has a fifty day moving average price of $20.74 and a 200 day moving average price of $21.85.

Confluent (NASDAQ:CFLTGet Free Report) last announced its earnings results on Monday, October 27th. The company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.03. Confluent had a negative net margin of 27.32% and a negative return on equity of 25.40%. The business had revenue of $298.52 million during the quarter, compared to analysts’ expectations of $292.69 million. During the same period in the prior year, the company earned $0.10 earnings per share. The business’s revenue was up 19.3% compared to the same quarter last year. Confluent has set its Q4 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.390-0.400 EPS. Sell-side analysts predict that Confluent will post -0.83 EPS for the current year.

Insider Transactions at Confluent

In other news, CRO Ban Ryan Norris Mac sold 15,200 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $17.01, for a total transaction of $258,552.00. Following the transaction, the executive directly owned 397,345 shares of the company’s stock, valued at $6,758,838.45. This represents a 3.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Rohan Sivaram sold 26,097 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $17.01, for a total transaction of $443,909.97. Following the completion of the sale, the chief financial officer owned 636,596 shares of the company’s stock, valued at $10,828,497.96. This trade represents a 3.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 741,584 shares of company stock valued at $13,597,695 in the last three months. Insiders own 9.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Confluent by 7.2% in the 1st quarter. Vanguard Group Inc. now owns 26,620,150 shares of the company’s stock valued at $623,976,000 after purchasing an additional 1,791,588 shares in the last quarter. Nuveen LLC acquired a new stake in Confluent in the first quarter valued at $28,791,000. Blair William & Co. IL increased its position in shares of Confluent by 8.6% in the second quarter. Blair William & Co. IL now owns 160,575 shares of the company’s stock valued at $4,003,000 after buying an additional 12,654 shares in the last quarter. Coronation Fund Managers Ltd. purchased a new position in shares of Confluent in the second quarter valued at $10,250,000. Finally, SWS Partners raised its stake in shares of Confluent by 29.9% during the 2nd quarter. SWS Partners now owns 139,464 shares of the company’s stock worth $3,477,000 after buying an additional 32,134 shares during the last quarter. 78.09% of the stock is owned by hedge funds and other institutional investors.

About Confluent

(Get Free Report)

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.

See Also

Analyst Recommendations for Confluent (NASDAQ:CFLT)

Receive News & Ratings for Confluent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Confluent and related companies with MarketBeat.com's FREE daily email newsletter.